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Abstract-Pentazocine rapidly enters the brain after i.p. administration to rats. Using 
leukocytes as model mammalian cells, the uptake of this drug was studied. Morpho- 
logically intact and metabolically active rat leukocytes accumulated pentazocine in 
vitro against a concentration gradient. The 6- to IO-fold concentration of the drug was 
dependent upon the presence of glucose in the incubation medium and was strongly 
affected by metabolic inhibitors present in millimolar concentrations. Theuptake showed 
saturation kinetics in the concentration range of 1.7-14 x 10m5 M pentazocine and 
was competitively inhibited by analogue benzomorphan derivatives. Ouabain as well 
as sodium-free extracellular media had no effect on the uptake of pentazocine. The 
transport system for pentazocine in the leukocyte apparently differs from the rela- 
tively nonspecific amine pump which accumulates various organic bases in the blood 
platelet. 
PENTAZOCINE, [1,2,3,4,5,6-hexahydro-6,l I-dimethyl-3-(3-methyl-2-butenyl)-2,6-meth- 
ano-3-benzazocine-8-011, a clinically used benzomorphan derivative, has been reported 
to be a potent analgesic in man, with a rapid onset of acti0n.l In agreement with the 
latter clinical observation, it was found2 that pentazocine penetrates biological 
membranes quite easily and the blood-brain barrier seemed to have little restricting 
effect on the entry of this compound into the brain. Peak concentrations of penta- 
zocine in plasma and brain after i.p. administration were obtained at 2 and 10 min, 
respectively. Furthermore, over the range of 25-100 mg/kg of injected pentazocine, 
the ratio of concentration in plasma to concentration in brain remained unchanged. 
After this demonstration of a pronounced and rapid exchange of the drug between 
compartments separated by biological membranes, it was of interest to study the 
cellular mechanism of this transport. In selecting a biological system, leukocytes were 
chosen as conveniently available, morphologically typical mammalian cells. If a 
correlation between the biochemical behavior of leukocytes and that of other tissue 
cells were demonstrated, leukocytes could be used as model cells for the study of 
selected biochemical processes in organs not easily accessible through techniques of 
tissue sampling. 
EXPERIMENTAL PROCEDURES 
Materials. The sources of drugs were: Winthrop (pentazocine, cyclazocine) and 
Smith, Kline & French (phenazocine). Etazocine was kindly provided by Dr. J. E. 
Villarreal, Department of Pharmacology, The University of Michigan. Plasmagel, 
an artificial medium of suitable density used for the separation by sedimentation of 
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leukocytes and erythrocytes, was obtained from Laboratoire Roger Bellon, Neuilly, 
France. All common chemicals were of reagent grade. 
Separation and characterization of leukocytes. Male Sprague-Dawley rats weighing 
300 g were used. Blood was obtained from the venae cavae of the lightly anesthetized 
(diethylether) rats. An average of 12 ml blood was collected from each animal. 
Sodium heparinate was used as an anticoagulant. To 6 ml of blood in IO-ml tubes 
was added 2 ml Plasmagel; the tubes were gently mixed by inversion and incubated 
for 45 min at 37”. The supematant, containing the leukocytes, was carefully removed 
from the erythrocyte layer and centrifuged for 2 min at 500 g in the cold (2”). The 
pellet, containing the leukocytes and some contaminating erythrocytes, was then 
suspended in 2 ml of the incubation medium at 37” and the remaining red blood cells 
lysed by the rapid and forceful addition of 6 ml Hz0 from a syringe. After mixing for 
5 set by inversion, 2 ml of 3.4% NaCl was added and the mixture centrifuged for 2 
min at 500 g in the cold. Finally, the pellet containing the leukocytes was resuspended 
in the incubation medium. 
The yield of cells was determined by manual cell counting using an A0 Spenser 
Bright Line hemacytometer. Protein was determined according to Lowry et a1.3 
Hemoglobin was estimated by measuring cyanomethemoglobin at 450 nm.4 The 
leukocyte preparation was examined microscopically using Wright’s stain. For the 
determination of the cellular concentrations of sodium and potassium, the thoroughly 
washed leukocytes were digested with 70 ‘A HN03 in polypropylene tubes for 30 min 
at 80”. After the appropriate dilution with LiCl standard, the measurements were 
performed in an IL flame photometer. Oxygen uptake was measured in air, using a 
Gilson differential respirometer. 
Incubation, extraction and gas chromatography of drugs. The incubations were 
performed at 37”. The basic incubation medium contained final millimolar concen- 
trations of: NaCl, 154; KCl, 2.68; MgCl,, 1.15; CaCl,, l-78; NaHCO,, 11.9; KH, 
P04, 0.37; and glucose, 5.55. The pH of the medium was adjusted to 7.4 with HCl. 
The extraction of the drugs and their gas chromatographic determination were 
performed essentially as described previously. 5 To insure membrane damage, the 
cellular preparation was subjected to repeated freezing (-70”) and thawing prior 
to the extraction. The pH of 1 ml of the cellular suspension was adjusted to 8.5 with 
0.05 N NaOH and the drugs were extracted with 10 ml benzene. 8-ml aliquots 
were evaporated and used for the gas chromatographic analysis. In most experiments 
cyclazocine (see Fig. 7) was used as the internal gas chromatographic standard. 
RESULTS 
Characterization and viability of the leukocyte preparation. The yield of leukocytes 
ranged from 5 x lo6 to 1 x 10’ cells/ml of rat blood. A cell number of 1 x lo6 cor- 
responded to approximately 50 pg protein. The average leukocyte preparation con- 
tained 80 per cent lymphocytes and 20 per cent granulocytes. Microscopic examination 
after the lysis step showed absence of intact erythrocytes and the hemoglobin con- 
centration was below our detection limit (0.4 per cent). The Na+ and K+ content of 
the leukocytes averaged to l-2 and 6-3 m-equiv./108 cells. The oxygen consumption 
at 37” of the suspension of leukocytes (10’ cells/ml) in 150 mM Krebs-Ringer phos- 
phate buffer @H 7.4) was 5-7 pl/lO’ cells/hr. The consumption was linear over a 
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FIG. 1. Oxygen uptake of the Ieukocyte preparation. Suspensions of leukocytes (lo7 ceils/ml) in the 
incubation medium (pH 7.4) described in the text were incubated at 37” for the indicated lengths of 
time in 1.5ml vessels of a Gilson respirometer in air. The results of a representative experiment are 
given. The points represent averages of two individual measurements. The mean f standard devia- 
tion for eight experiments was 6-l A 1.5 ~1 02/107 cells/hr. 
period of 4 hr (Fig. 1). During this time period, the cell count and the initial ratio of 
Na+/K+ remained also constant. In addition, a microscopic examination of the 
stained cellular preparation after 4 hr of incubation at 37” in the Krebs-Ringer 
solution or in the incubation medium used in other experiments (see below) revealed 
no change in the appearance of the cells. 
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FIG. 2. Uptake in vitro of pentazocine by rat leukocytes. Leukocytes were incubated at 37” for the 
various times indicated, using the incubation medium (pH 7.4) described in the text. In addition, the 
medium contained an initial concentration of 3-4 X IO-’ M (IO pg/mi) pentazocine. The extraction 
of the drug and its estimation by gas chromato~phy were as described in the text. The results of a 
typical experiment are given. The points represent averages of results obtained from three individual 
incubations using the same preparation of leukocytes. The standard deviation about these averages 
did not exceed 9 per cent of the mean value. The mean uptake of pentazocine in 70 separate incuba- 
tions was 87.3 f 25-2 pg/g of cells. 
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FIG. 3. Concentration dependence of the uptake of pentazocine by rat leukocytes. Leukocytes were 
incubated at 37” for 30 min in the medium (pH 7.4) described in the text. In addition, the medium 
contained various concentrations of pentazocine ranging from 1.7 to 14 x 10e5 M. The extraction 
of the drug and its estimation by gas chromatography were as described in the text. At each concentra- 
tion of pentazocine, three experiments were carried out, except with 10 ug/ml for which six experi- 
ments were performed. The standard deviations about the mean values ranged from 0 to 13 per cent. 
Uptake of pentazocine by leukocytes. The leukocytes, when incubated at 37” in a 
medium (pH 7.4) containing glucose and pentazocine (l-7-14 x 10e5 M), accumu- 
lated the drug 6- to lo-fold. After incubation in a medium containing 10 pg/ml 
(3.5 x lOa M) of pentazocine, the average concentration of the drug at saturation 
was 87.3 pg/g of cells. The initial rate of uptake was very rapid (Fig. 2). More than 
70 per cent of the final cellular drug concentration was reached within the first 2 min. 
The uptake of pentazocine showed saturation kinetics (Fig. 3). When the reciprocal 
concentration of pentazocine in the incubation medium was plotted against the 
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I / Pentazocine (Ag/ml) 
FIG. 4. Double reciprocal plot of the extra- and intracellular concentrations of pentazocine during the 
uptake of the drug by rat leukocytes. Abscissa, concentration of pentazocine in the incubation medium 
ordinate, amount of pentazocine taken up by 10’ cells at saturation (30 min). Experimental conditions 
were as described in the legend for Fig. 3. 
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reciprocal amounts of the drug taken up by 10’ cells at saturation, a linear relation- 
ship was obtained (Fig. 4). From this graph, the apparent maximum possible con- 
centration of pentazocine in leukocytes (intercept at the ordinate) and the half-maxi- 
mum concentration of the drug in the medium necessary to achieve saturation (inter- 
cept at the abscissa) were determined. The values were 2.2 /Ig (O-7 x lo-* moles)/lO’ 
cells and 34.5 pg (1.2 x 10’ moles)/ml respectively. Methodological reasons prevented 
us from examining the linearity of the uptake prior to 2 min. Therefore, as a refer- 
ence point, the uptake at 30 min was chosen, at which time near saturation was reached 
(Fig. 2). 
Glucose dependency of the uptake. When glucose was omitted from the incubation 
medium and the cells were preincubated for 2 hr at 37” in order to deplete the intra- 
cellular glucose content, the usual 6- to lo-fold accumulation of pentazocine dimin- 
ished to l-3-fold (Fig. 5). If glucose (5.55 x 10m3 M) was added to the depleted 
cellular suspension, the uptake of the drug again increased (Fig. 5). 
E&ct of metabolic inhibitors. The uptake of pentazocine was inhibited by various 
metabolic inhibitors (Table 1) present in the concentration range of l-5 x 10s3 M, 
except NaF, which was 30 x 10m3 M in the incubation medium. Whereas cyanide 
had no effect, the other compounds reduced the uptake considerably. Strongest 






0.20 - 15 
min 
000 
+Glucose -Glucose After addition 
of glucose 
FIG. 5. Glucose dependency of the uptake of pentazocine by rat leukocytes. The first bar ( + Glucose) 
shows the uptake of pentazocine by leukocytes which were incubated at 37” for 30 min in the incuba- 
tion medium (PH 7.4) described in the text. The medium contained glucose (5% x 10e3 M) and 
pentazocine (3.5 x 10m5 M). The second bar (- Glucose) represents experiments in which leuko- 
cytes were preincubated at 37” for 2 hr in a glucose-free medium, and then pentazocine (3.5 x lo-” 
M) was added. After reincubation for 30 min, the cellular uptake of the drug was determined as 
described. The last two bars (After addition of glucose) represent the uptake of pentazocine by 
leukocytes at various times after the addition of glucose (5.55 x 10e3 M) to the initially preincu- 
bated cellular preparation in a glucose-free medium. The additional steps were as described. The 
results of a representative experiment are given. The values represent averages of results obtained 
from three individual incubations using the same preparation of leukocytes. The standard deviation 
about these averages did not exceed 5 per cent of the mean value. The standard deviation for three 
experiments was 14.5 per cent. 
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in medium Uptake of pentazocine inhibition 
(mM) (pg drug/lo7 cells) of uptake 
Control 0.42 + 0.03 
Sodium cyanide 2 0.42 f 0.07 0 
Sodium azide 2 0.31 ?c 0.02 26.2 
Dinitrophenol 2 0.24 & 0.04 42.8 
Sodium fluoride 30 0.20 * 0.02 52-4 
Iodoacetamide 3 0.07 + 0.03 83.3 
* Rat leukocytes were preincubated with various inhibitors at 37” for 
30 min in the incubation medium (pH 7-4) described in the text. After 
the addition of pentazocine (3-5 x 10m5 M), the tubes were incubated 
for an additional 30 min at 37”. The further treatment was as described in 
the text. The results h S.D. of six determinations are given. 
Inhibition of pentazocine accumulation by analogue benzomorphan derivatives. In 
the presence of cyclazocine, etazocine and phenazocine, respectively, the uptake of 
pentazocine was considerably reduced (Fig. 6). The analogues, present at concentra- 
tions of 0.3-7.3 x 10m4 M, inhibited the uptake up to 90 per cent. Future work, 
which will include a more convenient methodological approach, should further reveal 
the kinetics of this inhibition. The structures of the benzomorphan derivatives in 
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FIG. 6. Effect of analogous benzomorphans on the uptake of pentazocine by rat leukocytes. Leuko- 
cytes were incubated at 37” for 30 min in the incubation medium (pH 7.4) described in the text. The 
medium contained pentazocine (3.5 x 10m5 M) and in addition, cyclazocine, etazocine or phena- 
iocine, respectively, in the concentration range of 3-4 x 10m5 to 7.4 X lo-“ M. The extraction of 
pentazocine and its estimation by gas chromatography were as described in the text. Whereas cycla- 
zocine was generally used as the internal gas chromatographic standard, it was substituted by eta- 
zocine in experiments using cyclazocine as an inhibitor of the uptake. The results of a representative 
experiment are given. The values represent averages of results obtained from three individual incuba- 
tions using the same preparation of leukocytes. The standard deviation about these averages did not 
exceed 5 per cent of the mean value. The standard deviation for three experiments was 9.5 per cent. 
Uptake of benzomorphans by leukocytes 1631 
FIG. 7. Structures;of pentazocine and analogue benzomorphans used in this study. 
Sodium dependency of the uptake. The replacement of NaCl by choline chloride 
in the incubation medium had no effect on the uptake of pentazocine by leukocytes. 
Similarly, no change was observed when LiCl was substituted for NaCI. Finally, 
3 x 10m4 M ouabain had no effect on the transport of pentazocine. 
DISCUSSION 
After the observation of the rapid entry of pentazocine into brain after i.p. admin- 
istration,2 the uptake of this compound by a cellular preparation was investigated. 
Leukocytes were chosen as conveniently available, morphologically typical mam- 
malian cells. If a correlation between biochemical effects observed in leukocytes and 
those in tissues of organs difficult to access were established, the biochemical investi- 
gation of leukocytes, including the determination of drug concentrations in them, 
could prove a valuable approach in gaining biological information concerning remote 
areas of the body (e.g. brain). 
A valid criticism of our cellular preparation could be its morphological hetero- 
geneity, as it contains various types of leukocytes. However, the characterization of 
our leukocyte preparation showed no contamination by erythrocytes, a constant 
ratio of lymphocytes to polymorphonuclear cells and a constant Na+/K+ ratio 
together with a good reproducibility of the ratio of protein to cell count. The viability 
of the cells was proven by the linear uptake of oxygen for up to 4 hr of incubation 
at 37”. The obtained rate of 5-7 ~1 O&O’/hr compares favorably with those reported 
for leukocyte preparations from rabbit@ and man.‘** 
The findings of the present study revealed that pentazocine and analogue benzo- 
morphans accumulate in leukocytes against a concentration gradient. The transport 
process showed considerable dependence on the presence of glucose and was affected 
by metabolic inhibitors. In view of the high rate of glycolysis in leukocyteq9 it is of 
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interest that the strongest inhibition of drug uptake was obtained with iodoacetamide 
and fluoride, both potent glycolytic inhibitors. It is of further interest that the mean 
inhibition of the pentazocine transport caused by the latter two compounds (52 and 
81 per cent, respectively) correlates well with the average decrease of drug uptake 
caused by the absence of glucose (64 per cent). The relatively slow recovery of penta- 
zocine transport after the renewed addition of glucose to the depleted cellular prepara- 
tion (Fig. 5) indicates the necessity of an initial penetration of glucose into the intra- 
cellular compartment. 
Human blood platelets have been used as a convenient model for the adrenergic 
neuron.lO These blood cells were found to actively accumulate and store organic 
bases,“*r2 including biogenic amines such as serotonin and norepinephrine13-Is as 
well as dopamine.16 The data from these studies suggest the existence of a relatively 
nonspecific amine pump in the membrane of the platelet, responsible for the active 
uptake of the above compounds. In addition to the accumulation against a concen- 
tration gradient and its inhibition by metabolic inhibitors, the uptake process of 
organic bases by platelets was sodium dependent and inhibited by ouabain.1z*14 
As shown by the results presented here, the uptake of pentazocine into leukocytes 
fulfils the basic criteria for an active transport process. Although preliminary experi- 
ments indicated some inhibition of the uptake by epinephrine, detailed experiments 
in the present study demonstrated that the transport process is independent of sodium 
and not affected by ouabain. This finding suggests that the transport system for benzo- 
morphans in leukocytes described here is not part of the nonspecific amine pump of 
the blood platelet. Studies on the structure dependence of the transport system and its 
species specificity are now in progress. 
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